147 related articles for article (PubMed ID: 31520927)
1. Corrigendum to"An insight into the medicinal perspective of synthetic analogs of indole: A review" [Eur. J. Med. Chem. 180 (2019) 562-612 11516].
Thanikachalam PV; Maurya RK; Garg V; Monga V
Eur J Med Chem; 2019 Dec; 183():111680. PubMed ID: 31520927
[No Abstract] [Full Text] [Related]
2. Corrigendum to "6-Amino-2,4,5-trimethylpyridin-3-ols: A new general synthetic route and antiangiogenic activity" [Eur. J. Med. Chem. 74 (2014) 126-139].
Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
Eur J Med Chem; 2017 Dec; 141():734-735. PubMed ID: 28988929
[No Abstract] [Full Text] [Related]
3. Corrigendum to: Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib [Eur. J. Med. Chem. 172 (2019) 143-153].
Poratti M; Marzaro G
Eur J Med Chem; 2020 Jun; 195():112272. PubMed ID: 32251743
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Optimization of physicochemical properties for 4-Anilinoquinazoline inhibitors of trypanosome proliferation" [Eur. J. Med. Chem. 141 (2017) 446-459].
Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
Eur J Med Chem; 2018 May; 152():515. PubMed ID: 29754075
[No Abstract] [Full Text] [Related]
5. Corrigendum to 'Dihydroorotate dehydrogenase: A drug target for the development of antimalarials' [Eur. J. Med. Chem. 125 (2017) 640-651].
Singh A; Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2017 Mar; 128():346-347. PubMed ID: 28241929
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives" [Eur. J. Med. Chem. 92 (2015) 332-341].
Balaji B; Balakrishnan B; Perumalla S; Karande AA; Chakravarty AR
Eur J Med Chem; 2019 Aug; 175():1. PubMed ID: 31055148
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives" [Eur. J. Med. Chem. 143 (2018) 1396-1405].
Li ZH; Zhao TQ; Liu XQ; Zhao B; Wang C; Geng PF; Cao YQ; Fu DJ; Jiang LP; Yu B; Liu HM
Eur J Med Chem; 2019 Nov; 181():111387. PubMed ID: 31376565
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents" [Eur. J. Med. Chem. 162 (162) (2019) 203-211].
Su L; Li J; Zhou Z; Huang D; Zhang Y; Pei H; Guo W; Wu H; Wang X; Liu M; Yang CG; Chen Y
Eur J Med Chem; 2019 Apr; 168():385. PubMed ID: 30826513
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
Chen KF; Tai WT; Hsu CY; Huang JW; Liu CY; Chen PJ; Kim I; Shiau CW
Eur J Med Chem; 2018 Jan; 143():2015. PubMed ID: 29113744
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview" [Eur. J. Med. Chem. 194 (2020) 112260].
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 Nov; 205():112642. PubMed ID: 32750565
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors" [Eur. J. Med. Chem. 167 (2019) 1-9].
Patel H; Jadhav H; Ansari I; Pawara R; Surana S
Eur J Med Chem; 2020 Aug; 200():112413. PubMed ID: 32512481
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors" [Eur. J. Med. Chem. 180 (2019) 171e190].
Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
Eur J Med Chem; 2020 Jan; 186():111899. PubMed ID: 31787358
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges" [Eur. J. Med. Chem. 95 (2015) 35-40].
Yu B; Yu Z; Qi PP; Yu DQ; Liu HM
Eur J Med Chem; 2016 Nov; 124():248. PubMed ID: 27592393
[No Abstract] [Full Text] [Related]
15. Corrigendum to "New desulfured troglitazone derivatives: Improved synthesis and biological evaluation" [Eur. J. Med. Chem. 187 (2020) 111939].
Dupommier D; Muller C; Comoy C; Mazerbourg S; Bordessa A; Piquard E; Pawlak M; Piquard F; Martin H; De Fays E; Grandemange S; Flament S; Boisbrun M
Eur J Med Chem; 2020 Dec; 208():112834. PubMed ID: 32966897
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308].
Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2020 Aug; 200():112464. PubMed ID: 32512484
[No Abstract] [Full Text] [Related]
17. Corrigendum to 'Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-b1 pathway' [Eur. J. Med. Chem. 157 (2018) 229-247].
Li X; Lu C; Liu S; Liu S; Su C; Xiao T; Bi Z; Sheng P; Huang M; Liu X; Wei Y; Zhao L; Miao S; Mao J; Huang K; Gao S; Liu N; Qi M; Liu T; Qin S; Wei L; Sun T; Ning W; Yang G; Zhou H; Yang C
Eur J Med Chem; 2019 Feb; 163():403. PubMed ID: 30530191
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Design, synthesis, DFT study and antifungal activity of the derivatives of pyrazolecarboxamide containing thiazole or oxazole ring" [Eur. J. Med. Chem. 149 (2018) 170-181].
Yan Z; Liu A; Huang M; Liu M; Pei H; Huang L; Yi H; Liu W; Hu A
Eur J Med Chem; 2018 May; 152():392. PubMed ID: 29747120
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity" [Eur. J. Med. Chem. 138 (2017) 128-139].
Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2018 Aug; 156():302-303. PubMed ID: 30007243
[No Abstract] [Full Text] [Related]
20. Corrigendum to "From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action" [Eur. J. Med. Chem. 204 (2020) 112481].
Tran QTN; Tan DWS; Wong WSF; Chai CLL
Eur J Med Chem; 2021 Jan; 209():112943. PubMed ID: 33097302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
